title: Impact of adding enfuvirtide to the predictive value of the darunavir genotypic resistance score.
authors: Charlotte
authors: C
authors: Charpentier
authors: Sidonie
authors: S
authors: Lambert-Niclot
authors: Lucile
authors: L
authors: Larrouy
authors: Gilles
authors: G
authors: Peytavin
authors: Marc-Antoine
authors: MA
authors: Valantin
authors: Roland
authors: R
authors: Landman
authors: Christine
authors: C
authors: Katlama
authors: Patrick
authors: P
authors: Yeni
authors: Mathieu
authors: M
authors: Felices
authors: Françoise
authors: F
authors: Brun-Vézinet
authors: Vincent
authors: V
authors: Calvez
authors: Anne-Geneviève
authors: AG
authors: Marcelin
authors: Diane
authors: D
authors: Descamps
mesh_terms: D000069454:Darunavir; D024882:Drug Resistance, Viral; D000077560:Enfuvirtide; D005838:Genotype; D006678:HIV / Q000201:enzymology / Q000235:genetics*; D015700:HIV Envelope Protein gp41 / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D016015:Logistic Models; D010446:Peptide Fragments / Q000627:therapeutic use*; D017354:Point Mutation; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D015700:HIV Envelope Protein gp41; D017320:HIV Protease Inhibitors; D010446:Peptide Fragments; D013449:Sulfonamides; D000077560:Enfuvirtide; D000069454:Darunavir